INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 134 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2019. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $45,000 | -23.7% | 1,316 | -42.4% | 0.00% | -66.7% |
| Q3 2020 | $59,000 | +126.9% | 2,284 | -33.9% | 0.01% | -14.3% |
| Q3 2019 | $26,000 | +550.0% | 3,455 | +986.5% | 0.01% | +600.0% |
| Q2 2019 | $4,000 | – | 318 | +1573.7% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 19 | -98.6% | 0.00% | -100.0% |
| Q2 2018 | $24,000 | +60.0% | 1,335 | +36.5% | 0.01% | -27.3% |
| Q3 2017 | $15,000 | – | 978 | +4345.5% | 0.01% | – |
| Q4 2016 | $0 | – | 22 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
| Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
| SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
| RA Capital Management | 314,349 | $12,587,000 | 1.81% |
| WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
| Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
| Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
| EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
| Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
| WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |